IVIg Proves Effective for Dermatomyositis in Phase 3 Trial IVIg Proves Effective for Dermatomyositis in Phase 3 Trial

Prior to this trial, intravenous immune globulin had not been fully studied for the treatment of dermatomyositis.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news